Benitec Biopharma Limited (BNTC) vs Larimar Therapeutics, Inc. (LRMR)

Benitec Biopharma Limited and Larimar Therapeutics, Inc. are both Biotechnology companies. Benitec Biopharma Limited and Larimar Therapeutics, Inc. are of similar size ($344.9M and $336.2M). Across the 9 metrics below, Benitec Biopharma Limited leads on 6 and Larimar Therapeutics, Inc. on 3.

Valuation

Metric BNTC LRMR Biotechnology median
P/E n/m n/m 7.88
P/S 5,953.22 n/m 11.47
P/B 2.52 2.51 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 3,555.62 n/m 10.73
Earnings yield (10.25%) (63.31%) (28.84%)
Free cash flow yield (3.72%) (48.79%) (23.03%)

Profitability

Metric BNTC LRMR Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (33.21%) (138.41%) (57.72%)
Return on assets (32.28%) (108.53%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BNTC LRMR Biotechnology median
Revenue growth (TTM) (1.32%) — 5.64%
EPS growth (last fiscal year) 6.83% (71.97%) —
Revenue growth, 5-year CAGR 4.92% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BNTC LRMR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 34.00 4.70 4.73
Net debt to EBITDA 3.52 0.79 0.96

Dividend

Metric BNTC LRMR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BNTC LRMR Biotechnology median
Market cap 336.24m 344.89m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack